Search Result "drug-free nanotherapy."
Drug-free Nanotherapies for Cancer Treatment
Journal: Current Nanoscience
Volume: 17 Issue: 3 Year: 2021 Page: 463-474
Author(s): Pravin Shende,Prashant Saini
Nanotherapy Targeting the Tumor Microenvironment
Journal: Current Cancer Drug Targets
Volume: 19 Issue: 7 Year: 2019 Page: 525-533
Author(s): Bo-Shen Gong,Rui Wang,Hong-Xia Xu,Ming-Yong Miao,Zhen-Zhen Yao
Advances and Perspectives in Cancer Nanotherapy: The Added- Value of Nanocarriers
Journal: Current Nanomedicine
Volume: 7 Issue: 3 Year: 2017 Page: 170-190
Author(s): Costas Demetzos,Natassa Pippa,Stergios Pispas
Aptamers in Targeted Nanotherapy
Journal: Current Topics in Medicinal Chemistry
Volume: 15 Issue: 12 Year: 2015 Page: 1102-1114
Author(s): Anila Mathew,Toru Maekawa,D. Sakthikumar
Smart Drug-Delivery Systems for Cancer Nanotherapy
Journal: Current Drug Targets
Volume: 19 Issue: 4 Year: 2018 Page: 339-359
Author(s): Paola Sanchez-Moreno,Juan Luis Ortega-Vinuesa,Jose Manuel Peula-Garcia,Juan Antonio Marchal,Houria Boulaiz
Preclinical Findings for Targeted Nanotherapies to Hepatocellular Carcinoma
Ebook: Nanotherapeutics for the Treatment of Hepatocellular Carcinoma
Volume: 1 Year: 2022
Author(s):
Doi: 10.2174/9789815039740122010011
Future Direction of Nanotherapy in the Management of Hepatocellular Carcinoma
Ebook: Nanotherapeutics for the Treatment of Hepatocellular Carcinoma
Volume: 1 Year: 2022
Author(s):
Doi: 10.2174/9789815039740122010014
Application of Nanotherapeutics in Cancer Treatment
Ebook: Applications of Nanoparticles in Drug Delivery and Therapeutics
Volume: 1 Year: 2024
Author(s): Divya Bajpai Tripathy
Doi: 10.2174/9789815256505124010008
From Metallodrugs to Metallodendrimers for Nanotherapy in Oncology: A Concise Overview
Journal: Current Medicinal Chemistry
Volume: 19 Issue: 29 Year: 2012 Page: 4995-5010
Author(s): S. El Kazzouli,N. El Brahmi,S. Mignani,M. Bousmina,M. Zablocka,J. -P. Majoral
Aptamers and Their Potential in Site-Specific Nanotherapy Against Hepatocellular Carcinoma
Ebook: Nanotherapeutics for the Treatment of Hepatocellular Carcinoma
Volume: 1 Year: 2022
Author(s):
Doi: 10.2174/9789815039740122010009